YieldMax AI Option Income Strategy ETF

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

CLOU

AIYY

C3.ai Inc. (AI) shares rose 4.39% to $9.03 on a strong trading day, breaking a three-day losing streak. The S&P 500 Index increased by 0.77%, while the Dow Jones Industrial Average rose by 0.75%. C3.ai's stock remains 70.14% below its 52-week high of $30.24. In comparison, Microsoft Corp. rose 1.04%, while Alphabet Inc. Cl C and Cl A fell by 0.47% and 0.38%, respectively. Trading volume reached 5.2 million, surpassing the 50-day average of 4.7 million.

- Shares of C3.ai Inc. (AI) increased by 4.39% to $9.03 on a positive trading day for the stock market, with the S&P 500 and Dow Jones also experiencing gains.  
- This rise marked the end of a three-day losing streak, although C3.ai remains 70.14% below its 52-week high of $30.24 reached on May 29th.  
- The trading volume of 5.2 million shares exceeded the 50-day average of 4.7 million, highlighting active trading interest.

MarketWatch Automated

C3.AI

Global X Cloud Computing ETF

iShares Expanded Tech Software Sector ETF

SPDR S&P Software

S&P 500

Dow Jones Industrial Average

Microsoft

Alphabet - C

Alphabet

Factset Research

C3.Ai Inc. Stock Outperforms Competitors On Strong Trading Day

MSFT

MSFU

MSFL

MSFO

MSFX

Microsoft has invested over $100 billion in its partnership with OpenAI, as revealed in court testimony amid Elon Musk's lawsuit against OpenAI and Microsoft. Musk alleges that OpenAI has strayed from its nonprofit roots, with Microsoft facilitating this shift. Despite the legal challenges, Microsoft's investment in OpenAI is seen as a key strategic move, with a targeted return of $92 billion and a significant ownership stake valued at $135 billion. Analysts maintain a Strong Buy rating for MSFT, with a price target suggesting a 38.3% upside potential.

- Microsoft has invested over $100 billion in its partnership with OpenAI, including infrastructure costs to support its computing needs.  
- This testimony arose during Elon Musk's lawsuit against OpenAI and Microsoft, where Musk accuses them of straying from nonprofit goals.  
- Despite the legal issues, Microsoft's partnership with OpenAI remains a key focus, with a targeted $92 billion return from early investments, leading to a valuation of OpenAI at $852 billion.

Tip Ranks

Direxion Daily MSFT Bull 2X Shares

GraniteShares 2x Long MSFT Daily ETF

YieldMax MSFT Option Income Strategy ETF

T-Rex 2X Long Microsoft Daily Target ETF

OpenAI

Elon Musk Lawsuit Puts Microsoft's (MSFT) $100B OpenAI Deal in Focus

Anthropic is experiencing significant growth, potentially raising tens of billions in funding to reach a valuation of $950 billion, surpassing OpenAI. Cat Wu, head of product for Claude, emphasizes a focus on innovation over competition. Anthropic has released multiple AI models, including the cybersecurity model Mythos, which is restricted to select partners. Wu envisions a future where AI agents enhance productivity, allowing humans to focus on creative tasks. The company aims for proactive AI development in the coming months, enhancing user experience and efficiency.

- Anthropic is poised for a strong year, seeking to raise around $10 billion and potentially surpass OpenAI's valuation with significant growth among business customers.  
- Key figure Cat Wu emphasizes a focus on continuous improvement over competitor analysis, leading to rapid model releases and innovations like the Mythos cybersecurity tool.  
- Looking ahead, Wu anticipates a shift towards proactive AI capabilities that automate routine tasks, aiming to enhance productivity and enable users to explore more creative endeavors.

TechCrunch

Amazon

Apple

CrowdStrike

Anthropic’s Cat Wu says that, in the future, AI will anticipate your needs before you know what they are

DA Davidson has reaffirmed an "underperform" rating for C3.ai (NYSE:AI) and set a target price of $7.00, indicating a potential downside of 19.86% from the current price. Other analysts have mixed ratings, with Wedbush giving an "outperform" rating and a $15.00 target. C3.ai's stock is currently trading at $8.74, down 0.6%, with a market cap of $1.27 billion. The company reported a quarterly EPS of ($0.40), missing estimates, and a revenue decline of 46.1% year-over-year. Insider trading activity includes a sale by Chairman Thomas M. Siebel and a purchase by Director Jim H. Snabe.

- C3.ai's stock received an "underperform" rating from DA Davidson, with a price target of $7, indicating a potential 19.86% downside.  
- The company reported a quarterly EPS of -$0.40 and a revenue of $53.26 million, significantly below analysts' expectations, raising concerns about profitability.  
- Additionally, insider trading activity includes a sale by Chairman Thomas M. Siebel and a purchase by Director Jim H. Snabe, reflecting mixed signals from company leadership.

Market Beat

Bank of Montreal

JPMorgan Chase

Citizens Financial

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

C3.ai (NYSE:AI) Earns Underperform Rating from DA Davidson

TSLA

In the ongoing trial between Elon Musk and OpenAI CEO Sam Altman, Altman testified that Musk abandoned the nonprofit's mission, claiming he did not steal a charity. Musk's lawsuit alleges that Altman and others misused his $38 million donation for commercial purposes. The trial highlights contentious negotiations over OpenAI's corporate structure, with Musk seeking control and suggesting a merger with Tesla. Altman expressed concerns about Musk's management style and the impact of his departure on employee morale. OpenAI's for-profit subsidiary, established post-Musk's exit, is now valued at over $850 billion.

- OpenAI CEO Sam Altman testified in the ongoing lawsuit brought by Elon Musk, claiming Musk abandoned the organization he co-founded.  
- The trial highlights tense negotiations between the co-founders regarding OpenAI's future and corporate structure, resulting in Musk's departure from the board in 2018.  
- Altman faced intense cross-examination questioning his trustworthiness, while Musk maintained that the for-profit conversion contradicted OpenAI's original charitable mission.

CNBC

Tesla

GraniteShares 1.25 Long TSLA Daily ETF

Simplify Volt TSLA Revolution ETF

Direxion Daily TSLA Bull 2X Shares

ISHRS S&P Glb It

GraniteShares 2x Long TSLA Daily ETF

Nintendo

NVIDIA

Intel

NVIDIA Corporation

Altman details Musk's OpenAI fallout, says nonprofit was 'left for dead'

NBIS

Nebius Group is pivoting towards AI by acquiring Eigen AI for $643 million and securing contracts with Meta and Microsoft worth billions. With a $2 billion investment from Nvidia, Nebius aims to transition from an infrastructure provider to a higher-value AI platform. This shift raises concerns about capital spending and potential margin compression. Analysts project $15.2 billion in revenue by 2029, but caution exists regarding profitability. The investment narrative highlights both opportunities and risks for investors considering Nebius Group's future.

Simplywall

Nebius

Meta Platforms

Is Nebius’ Nvidia‑Backed AI Pivot Altering The Investment Case For Nebius Group (NBIS)?

C3.ai, Inc.'s average stock price target has increased from $8.18 to $8.27, indicating a potential downside of 13% based on the May 11 closing price. The consensus rating among 15 analysts has shifted to 'Hold', with 2 Buy, 7 Hold, and 6 Sell recommendations. Forecasts range from $6 to $15 per share. This information is sourced from estimates by 11 analysts and does not constitute investment advice.

- C3.ai, Inc. stock's average price target has increased from $8.18 to $8.27, with estimates from 11 analysts ranging from $6 to $15 per share.  
- The updated target indicates a potential downside of approximately 13% based on the closing price from May 11.  
- The consensus rating among 15 covering analysts has shifted to "Hold," consisting of 2 Buys, 7 Holds, and 6 Sells.

TradingView

C3.ai, Inc. Stock 12‑Month Price Target Raised to $8.27, Implies 13% Downside

OpenAI CEO Sam Altman testified in a trial against co-founder Elon Musk, who alleges that Altman and other executives are misappropriating charity funds. Altman refuted these claims, stating that OpenAI has evolved into a significant charity despite creating a for-profit arm. The lawsuit, initiated by Musk in 2024, accuses Altman and President Greg Brockman of self-enrichment, while they argue it is a competitive harassment following Musk's launch of his AI startup, xAI. The trial is nearing its conclusion with closing statements expected soon.

- OpenAI CEO Sam Altman testified in a trial against cofounder Elon Musk, centered on control over OpenAI after their partnership began in 2015.  
- Altman contested Musk's claims of theft from a charity, stating that OpenAI's restructuring into a for-profit entity has resulted in significant charitable contributions.  
- Musk's lawsuit alleges that Altman and Greg Brockman are profiting at the charity's expense, while Altman argues the suit is a competitive harassment following Musk's launch of xAI.

nbcnews

OpenAI’s Sam Altman takes the stand to defend against Elon Musk allegations

OpenAI is expanding its 'Trusted Access Program' to numerous European companies, aiming to enhance AI collaboration and integration across various industries. This initiative demonstrates OpenAI's commitment to fostering innovation and providing secure access to its AI tools for European enterprises.

CoinLive

AI TRENDS | OpenAI to Expand Trusted Access Program in Europe

YieldMax AI Option Income Strategy ETF(AIYY.US)

C3.Ai Inc. Stock Outperforms Competitors On Strong Trading Day

Elon Musk Lawsuit Puts Microsoft's (MSFT) $100B OpenAI Deal in Focus

Anthropic’s Cat Wu says that, in the future, AI will anticipate your needs before you know what they are

C3.ai (NYSE:AI) Earns Underperform Rating from DA Davidson

Altman details Musk's OpenAI fallout, says nonprofit was 'left for dead'